Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Takotsubo Cardiomyopathy | 6 | 2023 | 65 | 1.620 |
Why?
|
| Obesity | 10 | 2023 | 1230 | 1.530 |
Why?
|
| Pericardium | 5 | 2023 | 35 | 1.460 |
Why?
|
| Cardiomyopathies | 4 | 2023 | 123 | 1.290 |
Why?
|
| Atrial Fibrillation | 6 | 2023 | 837 | 1.290 |
Why?
|
| Coronary Artery Disease | 3 | 2023 | 310 | 1.220 |
Why?
|
| Ventricular Remodeling | 4 | 2020 | 83 | 1.090 |
Why?
|
| Intra-Abdominal Fat | 2 | 2019 | 34 | 1.050 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 270 | 0.820 |
Why?
|
| Blood Vessels | 2 | 2014 | 62 | 0.770 |
Why?
|
| Heart Valve Diseases | 3 | 2023 | 95 | 0.760 |
Why?
|
| Electrocardiography | 7 | 2022 | 554 | 0.740 |
Why?
|
| Adipose Tissue | 5 | 2023 | 295 | 0.740 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 834 | 0.720 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 176 | 0.690 |
Why?
|
| Pheochromocytoma | 1 | 2020 | 26 | 0.680 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 43 | 0.670 |
Why?
|
| Atherosclerosis | 3 | 2016 | 153 | 0.660 |
Why?
|
| Lipolysis | 1 | 2020 | 47 | 0.650 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 264 | 0.650 |
Why?
|
| Heart Failure | 4 | 2018 | 916 | 0.630 |
Why?
|
| Echocardiography | 5 | 2023 | 501 | 0.620 |
Why?
|
| Adiposity | 2 | 2023 | 83 | 0.610 |
Why?
|
| Echocardiography, Doppler | 2 | 2018 | 134 | 0.580 |
Why?
|
| Vascular Diseases | 2 | 2016 | 81 | 0.580 |
Why?
|
| Insulin | 2 | 2020 | 686 | 0.570 |
Why?
|
| Adipocytes | 4 | 2023 | 268 | 0.530 |
Why?
|
| Adipose Tissue, Brown | 2 | 2023 | 118 | 0.510 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 6 | 0.500 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2016 | 22 | 0.490 |
Why?
|
| Methylprednisolone | 1 | 2015 | 34 | 0.480 |
Why?
|
| Bradycardia | 1 | 2015 | 33 | 0.480 |
Why?
|
| Insulin Resistance | 2 | 2016 | 410 | 0.470 |
Why?
|
| Humans | 36 | 2025 | 63299 | 0.470 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2015 | 43 | 0.460 |
Why?
|
| Cardiac Catheterization | 2 | 2016 | 281 | 0.450 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 226 | 0.430 |
Why?
|
| Glucocorticoids | 1 | 2015 | 188 | 0.430 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 108 | 0.420 |
Why?
|
| Diastole | 3 | 2023 | 91 | 0.420 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 89 | 0.400 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 136 | 0.400 |
Why?
|
| Inflammation | 4 | 2017 | 1146 | 0.400 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 218 | 0.390 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 914 | 0.390 |
Why?
|
| Outpatients | 1 | 2013 | 142 | 0.390 |
Why?
|
| Ventricular Premature Complexes | 2 | 2022 | 21 | 0.360 |
Why?
|
| Macrophages | 2 | 2016 | 1038 | 0.350 |
Why?
|
| Coronary Angiography | 3 | 2019 | 201 | 0.340 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 506 | 0.330 |
Why?
|
| Thinness | 1 | 2009 | 44 | 0.320 |
Why?
|
| Thermogenesis | 3 | 2023 | 121 | 0.310 |
Why?
|
| Heart Failure, Diastolic | 1 | 2009 | 9 | 0.310 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2020 | 165 | 0.310 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2009 | 49 | 0.300 |
Why?
|
| Male | 18 | 2025 | 29823 | 0.280 |
Why?
|
| Heart Atria | 3 | 2023 | 138 | 0.280 |
Why?
|
| Diet | 1 | 2011 | 524 | 0.280 |
Why?
|
| Middle Aged | 13 | 2021 | 17555 | 0.270 |
Why?
|
| Stroke Volume | 2 | 2018 | 332 | 0.260 |
Why?
|
| Female | 18 | 2025 | 32793 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 542 | 0.250 |
Why?
|
| Body Mass Index | 1 | 2009 | 863 | 0.240 |
Why?
|
| Prognosis | 4 | 2018 | 1750 | 0.240 |
Why?
|
| Histone Deacetylases | 1 | 2025 | 66 | 0.230 |
Why?
|
| Aged | 12 | 2025 | 14396 | 0.230 |
Why?
|
| Energy Metabolism | 2 | 2025 | 379 | 0.230 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1084 | 0.220 |
Why?
|
| Metformin | 1 | 2025 | 73 | 0.220 |
Why?
|
| Systole | 2 | 2015 | 109 | 0.220 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 713 | 0.220 |
Why?
|
| Heart Ventricles | 3 | 2023 | 264 | 0.210 |
Why?
|
| Heart Valves | 2 | 2023 | 26 | 0.200 |
Why?
|
| Glutamine | 1 | 2023 | 46 | 0.200 |
Why?
|
| Animals | 11 | 2025 | 20634 | 0.200 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2023 | 44 | 0.200 |
Why?
|
| Fibrosis | 1 | 2023 | 160 | 0.190 |
Why?
|
| Aortic Valve Stenosis | 1 | 2025 | 188 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 388 | 0.190 |
Why?
|
| Massachusetts | 4 | 2013 | 2077 | 0.190 |
Why?
|
| Myocardial Ischemia | 2 | 2017 | 118 | 0.180 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2021 | 3 | 0.180 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2021 | 7 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 68 | 0.180 |
Why?
|
| Atrial Premature Complexes | 1 | 2021 | 13 | 0.180 |
Why?
|
| Glucose | 2 | 2023 | 467 | 0.180 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 15 | 0.170 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 7 | 0.170 |
Why?
|
| Diet, Reducing | 1 | 2020 | 27 | 0.170 |
Why?
|
| Uncoupling Protein 1 | 3 | 2020 | 49 | 0.160 |
Why?
|
| Hypertension | 1 | 2005 | 584 | 0.160 |
Why?
|
| Oxygen Consumption | 2 | 2020 | 209 | 0.160 |
Why?
|
| Subcutaneous Fat | 1 | 2019 | 47 | 0.160 |
Why?
|
| Weight Gain | 1 | 2020 | 169 | 0.150 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 738 | 0.150 |
Why?
|
| Cytokines | 3 | 2017 | 934 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 297 | 0.150 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 109 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 170 | 0.140 |
Why?
|
| Mice | 8 | 2025 | 10827 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2018 | 2076 | 0.140 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 97 | 0.140 |
Why?
|
| Lectins | 1 | 2017 | 41 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 67 | 0.130 |
Why?
|
| Adipogenesis | 1 | 2018 | 79 | 0.130 |
Why?
|
| Prevalence | 3 | 2010 | 1377 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 771 | 0.120 |
Why?
|
| Pulse Therapy, Drug | 1 | 2015 | 4 | 0.120 |
Why?
|
| Stem Cells | 1 | 2018 | 258 | 0.120 |
Why?
|
| Interferon Type I | 1 | 2017 | 187 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 5343 | 0.120 |
Why?
|
| NADPH Oxidases | 1 | 2015 | 69 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 104 | 0.120 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 174 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 121 | 0.120 |
Why?
|
| Ion Channels | 2 | 2016 | 89 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 90 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2016 | 149 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 5447 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 3762 | 0.110 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 102 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 3391 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2018 | 417 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2015 | 185 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 224 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 220 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2025 | 2107 | 0.110 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 4 | 0.110 |
Why?
|
| Autophagy | 1 | 2016 | 225 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2460 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2016 | 483 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1539 | 0.100 |
Why?
|
| ROC Curve | 1 | 2013 | 281 | 0.100 |
Why?
|
| Cause of Death | 1 | 2013 | 221 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1543 | 0.100 |
Why?
|
| Algorithms | 3 | 2022 | 1001 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5657 | 0.100 |
Why?
|
| Photoplethysmography | 2 | 2022 | 35 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 12 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 65 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2022 | 96 | 0.090 |
Why?
|
| Survival Rate | 1 | 2013 | 850 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2021 | 3285 | 0.090 |
Why?
|
| Torsades de Pointes | 1 | 2010 | 6 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 81 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 59 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 135 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 32 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6631 | 0.090 |
Why?
|
| Heart Rate | 2 | 2022 | 321 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2011 | 175 | 0.080 |
Why?
|
| Aortic Valve | 2 | 2025 | 190 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 661 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1191 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2152 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 893 | 0.080 |
Why?
|
| Heart Failure, Systolic | 1 | 2009 | 16 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 53 | 0.080 |
Why?
|
| Homeostasis | 2 | 2025 | 370 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 1168 | 0.070 |
Why?
|
| Biomarkers | 1 | 2013 | 1396 | 0.070 |
Why?
|
| Acute Disease | 1 | 2009 | 672 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2009 | 768 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2009 | 193 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2009 | 483 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 1275 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 972 | 0.060 |
Why?
|
| Aorta | 2 | 2018 | 113 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1560 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 122 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2009 | 874 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2009 | 469 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 139 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2014 | 3033 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2025 | 387 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2009 | 2570 | 0.050 |
Why?
|
| Histones | 1 | 2025 | 483 | 0.050 |
Why?
|
| Mitochondria | 1 | 2025 | 371 | 0.050 |
Why?
|
| Artifacts | 1 | 2022 | 125 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1617 | 0.040 |
Why?
|
| Perilipin-1 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 56 | 0.040 |
Why?
|
| Lipid Droplets | 1 | 2020 | 33 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 130 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 177 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2180 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 53 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 40 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 30 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2018 | 217 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 626 | 0.030 |
Why?
|
| Proprotein Convertase 1 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Enkephalins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 18 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2016 | 18 | 0.030 |
Why?
|
| Iodide Peroxidase | 1 | 2016 | 23 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 39 | 0.030 |
Why?
|
| Capillaries | 1 | 2016 | 30 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2016 | 57 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2015 | 34 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 2016 | 32 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2016 | 27 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2015 | 32 | 0.030 |
Why?
|
| United States | 1 | 2009 | 7828 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 97 | 0.030 |
Why?
|
| NADPH Oxidase 4 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2016 | 83 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 233 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2016 | 45 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 107 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1514 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 174 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 207 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 517 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 388 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 175 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 608 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 1200 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 469 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2015 | 297 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 211 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 566 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 695 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1276 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 985 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 16784 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 751 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4683 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1184 | 0.020 |
Why?
|